CG
DICE

Carmignac Gestion’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Carmignac Gestion’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-70,439
Closed -$3.27M – 176
2023
Q2 		$3.27M Buy
+70,439
New +$2.43M 0.06% 86

Carmignac Gestion's DICE Position: Q3 2023 in Review

Carmignac Gestion sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 70,439 shares — an estimated $3.27M sold.

Carmignac Gestion first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $3.27M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Carmignac Gestion reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Carmignac Gestion sold 70,439 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $3.27M.
  • Carmignac Gestion first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Carmignac Gestion's DICE Therapeutics, Inc. Common Stock position peaked at $3.27M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Carmignac Gestion's 13F filing for Q3 2023, filed 13 Nov 2023.